<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02140866</url>
  </required_header>
  <id_info>
    <org_study_id>109</org_study_id>
    <nct_id>NCT02140866</nct_id>
  </id_info>
  <brief_title>Hand Exercises for Women With Rheumatoid Arthritis and Impaired ADL Ability: an Exploratory Trial</brief_title>
  <acronym>RAHExercise</acronym>
  <official_title>Hand Exercises for Women With Rheumatoid Arthritis and Impaired ADL Ability: an Exploratory Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Parker Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Oak Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Aase and Ejnar Danielsens Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Danish Physiotherapy Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Danish Rheumatism Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Danish Association of Occupational Therapist</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Parker Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study examines whether hand exercise therapy as an add on to a compensatory intervention
      program focused on joint protection, assistive devices and alternative methods of doing will
      improve the performance of ADL tasks requiring hand function in patients with rheumatoid
      arthritis (RA).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Actual">May 2016</completion_date>
  <primary_completion_date type="Actual">March 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The Assessment of Motor and Process Skills (AMPS) - the motor skill scale</measure>
    <time_frame>within 2 weeks post intervention</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The Assessment of Motor and Process Skills(AMPS) - the process skill scale</measure>
    <time_frame>within 2 weeks post intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Activities of Daily Living Questionnaire (ADL-Q)</measure>
    <time_frame>within 2 weeks post intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health Assessment Questionnaire (HAQ)</measure>
    <time_frame>within 2 weeks post intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall disease activity (DAS-28)</measure>
    <time_frame>within 2 weeks post intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Grip strength</measure>
    <time_frame>within 2 weeks post intervention</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Ultrasound Doppler</measure>
    <time_frame>within 2 weeks post intervention</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">55</enrollment>
  <condition>Rheumatoid Arthritis</condition>
  <arm_group>
    <arm_group_label>Hand Exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The intervention group will receive an exercise program for the hand/arm in combination with a compensatory intervention program (CIP).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Compensatory Intervention Program (CIP)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The control group will receive the Compensatory Intervention Program (CIP) only.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hand Exercise</intervention_name>
    <arm_group_label>Hand Exercise</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Compensatory Intervention Program (CIP)</intervention_name>
    <arm_group_label>Compensatory Intervention Program (CIP)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female sex.

          -  Age ≥ 18.

          -  Diagnosis of rheumatoid arthritis (2).

          -  Involvement of the hands, due to minimum one tender wrist, metacarpophalangeal (MCP)
             or proximal interphalangeal (PIP) joint in one of the hands.

          -  Be on stable medication for at least 3 months prior to participation.

          -  Self-reported decreased ability to perform personal and instrumental ADL tasks
             involving the hands.

        Exclusion Criteria:

          -  Significant osteoarthritis of the hand assessed at the initial examination by the
             rheumatologist

          -  Hand surgery within 6 months of study participation

          -  Other pain condition involving muscles and/or joints, e.g. fibromyalgia.

          -  Prednisolon therapy, change in dose of biological agent or start of treatment with a
             new biological agent within the last 3 month before study start.

          -  Inability to understand the information or to speak Danish

          -  Any other condition that in the opinion of the investigator or accessing
             rheumatologist puts an otherwise eligible participant at increased risk by
             participation or otherwise make the person unfit for participation.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eva E Wæhrens, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Parker Research Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Copenhagen University Hospital, Frederiksberg</name>
      <address>
        <city>Frederiksberg</city>
        <zip>2600</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 2, 2014</study_first_submitted>
  <study_first_submitted_qc>May 14, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 16, 2014</study_first_posted>
  <last_update_submitted>September 19, 2017</last_update_submitted>
  <last_update_submitted_qc>September 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Parker Research Institute</investigator_affiliation>
    <investigator_full_name>Eva Ejlersen Wæhrens</investigator_full_name>
    <investigator_title>Senior researcher, PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

